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Background:Women with stress urinary incontinence and concomitant obstructive (voiding) lower urinary tract symptoms (LUTS)
represent a challenging patient population. Furthermore, their diagnosis and management remain incompletely studied and
controversial. We evaluated the outcomes of midurethral sling procedures in women with severe obstructive LUTS.
Methods: We performed a post hoc analysis of women who were part of an institutional review board-approved study of
midurethral sling surgery. Preoperatively and at 4-6 weeks postoperatively, patients completed the American Urological
Association Symptom Score (AUASS) questionnaire. A postvoid residual urine test was obtained preoperatively, at the time of the
voiding trial, and 4-6 weeks postoperatively. Three groups of patients with severe LUTS were then defined: Group A (AUASS ‡20),
Group B (voiding subscale ‡12), and Group C (urodynamic obstruction). Patients could be included in more than one group.
AUASS was again obtained at a medium-term follow-up of 31.6 months.
Results: Of 106 women completing follow-up, 30, 23, and 11 subjects met the criteria for groups A, B, and C, respectively. All had
statistically significant improvements in storage and voiding subscales, as well as their stress urinary incontinence. No subject
presented with retention or voiding dysfunction at follow-up. These improvements continued at medium-term follow-up with the
exception of Group C that failed to demonstrate persistence of statistical improvement in AUASS subscales.
Conclusion: Patients with stress urinary incontinence and severe voiding LUTS can be treated safely with midurethral sling
procedures. In both the short and medium term, these symptoms improve dramatically in the majority of patients.
Keywords: Lower urinary tract symptoms, suburethral slings, urinary incontinence–stress
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INTRODUCTION
Midurethral synthetic sling surgery has become the most
common antiincontinence procedure performed in the
developed world, with more than 1 million procedures
performed in the last 2 decades.1,2 Many types of sling kits
are available that allow placement of a mesh in either a
retropubic or a transobturator fashion. Both methods have
good outcomes, and long-term cure and significantly
improved rates exceed 90%.3 However, the best modality
to treat patients with complicated cases of stress inconti-
nence is still debated.
Specifically, patients with concomitant voiding lower urinary
tract symptoms (LUTS) and stress urinary incontinence
represent a challenging subset to diagnose and manage.4
LUTS can include storage symptoms (urinary urgency,
urinary frequency, urgency incontinence) and voiding symp-
toms (urinary hesitancy, urinary straining, decreased force of
stream, incomplete emptying). A paucity of data exists in the
literature on LUTS in the female patient, likely because of its
lower incidence compared to male obstruction related to
benign prostatic hyperplasia and the lack of agreed-upon
criteria. Additionally, dysfunctional voiding may be present in
neurologically normal women with no prior urologic history
and can further confound decision-making in this patient
population.5 Nevertheless, an assortment of definitions of
LUTS in women now exists based on objective and subjective
criteria. Certain components of LUTS, such as a weak urinary
stream and urinary hesitancy, are well-known complications
of antiincontinence surgery. However, to our knowledge, no
study has shown improvements when such symptoms exist
at baseline. Our institution conducted a prospective study of
women undergoing sling surgery to evaluate LUTS. We
evaluated a population of women who underwent a midure-
thral sling procedure and had severe LUTS based on their
American Urological Association Symptom Score (AUASS).
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METHODS
This study was conducted as a planned post hoc analysis
of data obtained from an institutional review board-approved
prospective study of midurethral sling procedures performed
at our institution. Subjects who were scheduled to undergo
isolated midurethral synthetic sling surgery were recruited in
the office setting of 4 fellowship-trained urologists in female
pelvic medicine and reconstructive surgery. Informed con-
sent to participate in the study was obtained. Patients who
had had prior antiincontinence procedures were included in
the study population. Women who required concomitant
pelvic organ prolapse surgery, urethrolysis, or other proce-
dures were excluded from participation.
Subjects completed an AUASS questionnaire at their
preoperative visit to determine subjective voiding (obstructive)
symptoms. Postvoid residualmeasurementswere recordedat
the preoperative visit, at the time of the voiding trial, and 4-6
weeks postoperatively. Urodynamic investigations were per-
formed at the discretion of the surgeon.
The AUASS was developed initially for evaluating male
patients with benign prostatic hyperplasia with obstructive
and irritative voiding symptoms.6 Subsequent studies evalu-
ated sex differences between AUASSs and found no evidence
of a sex difference when evaluating women with this tool.7,8
Scarpero et al further demonstrated that the AUASS
accurately reflects LUTS in women and is a good indicator
of the ‘‘degree of bother’’ and effect on quality of life.9 The
AUASS is determined by a 7-item questionnaire that asks
about both storage symptoms and obstructive symptoms
(Figure).6 Each item is scored 0-5 based on frequency of
urinary complaints, and the total score is 0-35. Patients with
scores ‡20 are defined as the severe symptom group. The 7
items can be further divided into storage questions (questions
2, 4, and 7) and voiding questions (questions 1, 3, 5, and 6).
Figure. American Urological Association Symptom Score.6
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An eighth question asks about quality of life related to urinary
symptoms and is scored from 0 (delighted) to 6 (terrible).
Definitions of Severe LUTS
We evaluated 3 categories of patients with severe LUTS.
First, we evaluated subjects with a total score ‡20 on the
AUASS questionnare (Group A). Second, to evaluate
patients who had primarily outlet-related symptoms, we
evaluated the patients with a voiding score ‡12 (Group B).
This score on the voiding subscale corresponds to an
average of having such voiding-related symptoms (ques-
tions 1, 3, 5, and 6) ‘‘about half the time’’ or more often.
Last, to evaluate obstruction as a possible etiology of
severe LUTS, our third group was based on urodynamic
definitions of obstruction (Group C). We defined urody-
namic outlet obstruction as a maximum flow of 12 mL/s,
with a detrusor pressure at maximum flow of ‡20
cmH2O.
10 Patients could be included in one or more of
these 3 categories of LUTS.
Operative Procedure
The choice of midurethral sling was determined by the
surgeon. All 4 surgeons routinely perform retropubic and
transobturator sling surgery, and both modalities were used
in this patient population. All sling procedures were
performed under general or local anesthetic with intrave-
nous sedation. No subject had a spinal anesthetic. All
patients had a voiding trial within 1 hour of arrival to
recovery, during which 300 mL of fluid was instilled in a
retrograde fashion through the Foley catheter.
Postoperative Care
Subjects failing the voiding trial returned to the office
within 48-72 hours for a repeat trial. All other subjects were
telephoned within the first week to ensure that they were
voiding without problems and had no signs or symptoms of
urinary tract infection. Subjects had a postoperative visit 4-6
weeks after surgery. At the follow-up visit, each subject had
a repeat postvoid residual check and completed a postop-
erative AUASS questionnaire. To obtain medium-term
follow-up, patients were contacted more than 2 years after
surgery and administered the AUASS questionnaire by
trained study personnel.
Statistical Analysis
Statistical calculations were carried out using SAS 9.2
(SAS Institute, Inc.). Preoperative values of the AUASS were
compared to postoperative values using the paired Student
t test. Identical calculations were performed to analyze
voiding scores, symptom subscores, and postvoid residual
measurements.
RESULTS
A total of 106 women underwent solitary sling surgery at
our institution and completed their follow-up. Using the
definitions of a preoperative AUASS ‡20, a voiding score
‡12, or urodynamically proven obstruction, 30, 23, and 11
women were classified as having severe symptoms,
respectively. All but 2 (93.3%) of the 30 subjects with LUTS
had baseline urodynamic evaluations. Baseline demograph-
ic data and urodynamic parameters are shown in Tables 1
and 2. The mean body mass index of the study population
was 31 – 7.3 kg/m2.
All groups had significant improvements in total AUASS,
storage score, and voiding score after sling surgery (Table
3). These significant improvements persisted to medium-
term follow-up (mean time of 31.6 [range, 27-35] months)
with the exception of Group C (urodynamic obstruction).
Postvoid residual values at baseline, at the time of the
voiding trial, and at the follow-up visit are shown in Table 4.
At the time of the immediate postoperative voiding trial,
residual volumes increased significantly but then dropped
to nearly the preoperative value at the postoperative follow-
up visit. No differences were seen between subjects who
had a retropubic sling or a transobturator sling with respect
to urodynamic evidence of obstruction, AUASS, voiding
scores, or storage scores.
Five of the 30 patients with an AUASS ‡20 failed the initial
voiding trial and required catheterization upon discharge.
However, all 5 passed the subsequent voiding trial within 48-
72 hours. Two of the 30 (6.7%) patients developed a
symptomatic urinary tract infection prior to their postoperative
visit and required antibiotic therapy. No patient returned to the
office or had any emergency department visits related to acute
voiding dysfunction or urinary retention.
Table 2. Baseline Urodynamic Parameters for Patients
with an AUASS ‡20 (n¼28)
Urodynamic Parameter Mean SD
Abdominal leak-point pressure, cmH2O 108.7 40.0
Detrusor pressure at maximum flow rate,
cmH2O 26.3 22.3
Maximum flow rate, mL/s 17.1 9.8
Postvoid residual urine, mL 27.6 35.2
AUASS, American Urological Association Symptom Score.
Table 1. Baseline Demographics for Patients with an
AUASS ‡20 (n¼30)
Variable n %
Married 20 66.7
Caucasian 28 93.3
Employed 16 53.3
Medical Condition
Diabetes 3 10.0
Neurogenic bladder 5 16.7
Mixed incontinence 25 83.3
Surgical History
Prior antiincontinence surgery 11 36.7
Prior hysterectomy 20 66.7
Prior prolapse surgery 8 26.7
Type of Sling
Transobturator 13 43.3
Retropubic 17 56.7
AUASS, American Urological Association Symptom Score.
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DISCUSSION
Our planned post hoc analysis shows that in patients with
severe LUTS and concomitant stress urinary incontinence,
both retropubic and transobturator slings are safe and
effective in the short and medium terms. The management of
patients presenting with concomitant stress incontinence and
severe LUTS is often challenging. Only one prior study, Ballert
et al in 2008, has evaluated LUTS with the AUASS before and
after midurethral sling surgery.11 In that series, the authors
reported on 100 consecutive patients who underwent solitary
sling surgery and had a statistically significant decrease of 3.6
points in total AUASS after surgery. Voiding scales were also
calculated, but, unlike our study, no significant change was
seen after surgery. The population was a heterogeneous
cohort, and the mean preoperative total AUASS was 14.1.
Clearly, our population, with a mean AUASS of 24.6 at
baseline, demonstrated much more severe symptoms at
baseline than the patients evaluated in the Ballert et al study.
A possible explanation for why subjects with stress
urinary incontinence have such high AUASSs relates to
so-called ‘‘defensive voiding.’’ Patients with stress urinary
incontinence may realize that leakage is more common with
a full bladder. As a result, these patients might void with a
higher frequency to keep their bladders empty. In a study
evaluating voiding diaries in subjects with stress urinary
incontinence and overactive bladder, not surprisingly, the
overactive bladder population had a higher daytime voiding
frequency than the pure stress urinary incontinent popula-
tion.12 Interestingly, however, subjects with pure stress
urinary incontinence had high voiding frequency (median
74th reference population percentile) and relatively low
volume per void (median 29th reference population per-
centile). This could potentially explain some of the baseline
complaints in our study. In addition, patients with prior
antiincontinence procedures were not excluded, and
residual changes to the outlet after prior surgeries could
persist and increase the baseline AUASS. Improvement of
storage symptoms after sling surgery has been well
documented in prior studies.11,13 However, the idea that
placement of a sling might improve LUTS and potentially
obstructive symptoms is counterintuitive. While it is reason-
able to assume that a tension-free sling should not worsen
obstructive symptoms, the improvement of these symptoms
in many patients was unexpected. A possible explanation is
that patients with stress urinary incontinence may guard to
prevent leakage, leading to an element of dysfunctional
Table 3. AUASS Total Scores and Subscores by Group
Parameter
Preoperative
Postoperative
(short-term, 4-6 weeks)
Postoperative
(medium-term, 27-35 months)
Mean SD Mean SD P Value Mean SD P Value
Group A
Patients with AUASS ‡20 (n¼30)
AUA storage score 11.87 2.16 3.77 3.07 <0.0001 8.33 4.39 0.0013
AUA voiding score 12.73 3.34 5.53 3.43 <0.0001 7.53 4.82 <0.0001
Total AUASS 24.57 3.79 9.30 5.90 <0.0001 15.87 8.45 <0.0001
AUA QOL score 5.00 1.36 1.60 1.48 <0.0001
Group B
Patients with voiding score ‡12 (n¼23)
AUA storage score 11.61 2.27 4.82 3.00 <0.0001 8.27 4.86 0.0096
AUA voiding score 14.74 2.72 4.82 3.56 <0.0001 8.72 5.64 0.0002
Total AUASS 26.35 3.82 9.65 5.52 <0.0001 17.00 10.00 0.0004
AUA QOL score 5.17 1.07 1.24 1.25 <0.0001
Group C
Patients with BOO on UDS (n¼11)
AUA storage score 8.55 3.72 5.18 3.31 0.0171 10.00 4.47 0.4783
AUA voiding score 6.91 5.80 2.09 2.39 0.0202 9.57 7.07 0.7562
Total AUASS 15.45 8.45 6.82 4.47 0.0014 19.57 10.73 0.6209
AUA QOL score 4.82 0.98 1.36 1.12 <0.0001
AUA, American Urological Association; AUASS, American Urological Association Symptom Score; BOO, bladder outlet obstruction; QOL, quality of life;
SD, standard deviation; UDS, urodynamics.
Table 4. Postvoid Residual Urine for Patients with an
AUASS ‡20 at Baseline, Time of Voiding Trial, and
Follow-Up
Time Point
Postvoid Residual
Urine, mL
P ValueMean SD
Preoperative 27.6 35.3 0.0016,a 0.2975b
Voiding trial in recovery 123.9 143.2
Postoperative 41.7 58.6
AUASS, American Urological Association Symptom Score.
aCompared to the voiding trial.
bCompared to the postoperative time point.
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voiding that may resolve when the fear of stress urinary
incontinence is gone.
Furthermore, afferent nerve fibers in the urethra are known
to facilitate voiding by activating bladder parasympathetics.14
Frequent stimulation of these afferent nerves secondary to
incontinence could lead to sensations of the need to void to
which the patient responds by contracting the pelvic floor,
developing a form of dysfunctional voiding. Correction of
urinary incontinence may, in fact, aid by eliminating this
urethral stimulation andbreaking this dysfunctional cycle, thus
facilitating flow. Regardless, in the medium term the only
patients who did not continue to have significant improvement
in the obstructive symptoms were those with urodynamically
documented obstruction. Patients who had only subjective
obstructive symptoms continued to show improvement.
Our study has several limitations. We evaluated short-term
results at 4-6 weeks postoperatively with the AUASS and
postvoid residual test but for logistical reasons were unable to
obtain a repeat postvoid residual test for the medium-term
follow-up. Although voiding LUTS improved in the short term
and persisted to the medium-term follow-up, whether such
symptomswill revert to baseline in the long term remains to be
determined, but reversion to baseline seems unlikely, as there
is no trend toward that at present. Similarly, we did not obtain
quality of life scores at medium-term follow-up. Last, while
urodynamic evaluations were performed in all but 2 patients
preoperatively, we did not obtain postoperative studies. Prior
studies have shown significant changes in peak flow 1 year
after sling surgery.15 The impact of slings on flow and voiding
pressures in our severe symptom group is unknown.
CONCLUSION
We have shown that patients with stress urinary inconti-
nence and severe voiding LUTS based on a variety of
definitions can be treated safely with midurethral slings. No
worsening of obstructive symptoms occurs, and in the short
and medium term, severe symptoms seem to improve
dramatically, resulting in significant improvement in quality
of life for the majority of patients.
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